Methylnaltrexone
Term · Oncology and biomedicine · MLC-T-ONC-015138
A methyl derivative of noroxymorphone with selective, opioid-receptor antagonistic activity. Methylnaltrexone displaces opioids from peripheral opioid receptors in the gastrointestinal tract, the bladder, and the skin, resulting in decreases in opioid-related constipation, urinary retention, and pruritis, respectively. Methylnaltrexone does not cross the blood-brain barrier and does not affect the centrally-mediated analgesic effect of opioids.
| Identifier | MLC-T-ONC-015138 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MNTX |
| Synonyms | N-methylnaltrexone bromide; quaternary ammonium naltrexone |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015138",
"term": "Methylnaltrexone",
"field": "Oncology and biomedicine",
"definition": "A methyl derivative of noroxymorphone with selective, opioid-receptor antagonistic activity. Methylnaltrexone displaces opioids from peripheral opioid receptors in the gastrointestinal tract, the bladder, and the skin, resulting in decreases in opioid-related constipation, urinary retention, and pruritis, respectively. Methylnaltrexone does not cross the blood-brain barrier and does not affect the centrally-mediated analgesic effect of opioids.",
"abbreviation": "MNTX",
"synonyms": [
"N-methylnaltrexone bromide",
"quaternary ammonium naltrexone"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/methylnaltrexone/"
}
Record 10,954 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.